The currently licensed vaccines against influenza work either on the principle of inactivated or live attenuated vaccination protocols or those devised on principles of subunit vaccines which majorly incorporate the influenza viral particles such as surface proteins HA, and NA fragments [33], [35], [35]. The gene discussed is XK; the disease is influenza.